Latest China Nepstar Chain Drugstore Ltd (NPD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest China Nepstar Chain Drugstore Ltd (NPD) Headlines

Buy-Rated Dividend Stocks: Top 3 Companies: NPD, BKCC, CLCT
at The Street - Mon Mar 10, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

China Nepstar Chain Drugstore to Report Fourth Quarter and Fiscal Year 2013 Financial Results on March 28, 2014
PR Newswire - Fri Mar 07, 6:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its unaudited financial results for the fourth quarter and fiscal year 2013 on Friday, March 28, 2014 before the market opens.

3 Buy-Rated Dividend Stocks Taking The Lead: NPD, PZN, AB
at The Street - Thu Feb 27, 10:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

Rite Aid Q3 Earnings in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 20, 7:50AM CST
Rite Aid posted third-quarter fiscal 2014 earnings of 4 cents per share, which was in line with the Zacks Consensus Estimate.

China Nepstar Chain Drugstore (NPD) Jumps: Stock Rises 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 7:21AM CST
China Nepstar Chain Drugstore Ltd. (NPD) was a big mover last session, as the company saw its shares rise by over 7% on the day.

Tomorrow's Ex-Dividends To Watch: NPD, DHG, CII, BKCC, IGT
at The Street - Tue Dec 17, 9:00AM CST
NPD DHG CII BKCC IGT are going ex-dividend tomorrow, Wednesday, Dec. 18, 2013, 5:00 AM ET

China Nepstar Chain Drugstore Ltd's board to pay USD0.32 per ADS annual dividend
M2 - Tue Nov 26, 6:58AM CST
The board of directors of China Nepstar Chain Drugstore Ltd (NYSE:NPD), a retail drugstore chain in China, on Tuesday declared its annual cash dividend of USD0.32 per American Depositary Share (ADS).

China Nepstar Chain Drugstore Announces Annual Dividend
PR Newswire - Tue Nov 26, 1:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared an annual cash dividend of US$0.32 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31.59 million. The distribution of the dividend is conditional upon the approval of the relevant PRC government authorities. The annual dividend is payable before or around January 24, 2014 to shareholders of record as of the close of business on December 20, 2013.

China Nepstar Chain Drugstore Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 26, 1:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2013.

China Nepstar Chain Drugstore to Report Third Quarter 2013 Financial Results on November 26, 2013
PR Newswire - Wed Nov 06, 5:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its unaudited financial results for the third quarter ended September 30, 2013 on Tuesday, November 26, 2013 before the market opens.

Rite Aid Q2 Earnings Beat, Stock Hits 5-Yr High - Analyst Blog
Mark Vickery - Zacks Investment Research - Fri Sep 20, 7:30AM CDT
Driven by higher adjusted EBITDA and lower interest expenses, Rite Aid posted a quarterly profit for the fourth consecutive quarter.

China Nepstar Chain Drugstore swings to loss in Q2 2013
M2 - Fri Aug 30, 8:24AM CDT
China Nepstar Chain Drugstore Ltd (NPD), a retail drugstore chain in China, on Thursday reported a net loss of CNY3.9m, or CNY0.04 per basic and diluted ADS, for the second quarter of 2013, ended 30 June 2013.

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 29, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2013.

China Nepstar Chain Drugstore Ltd. to Report Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 08, 5:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its unaudited financial results for the second quarter ended June 30, 2013 on Thursday, August 29, 2013 before the market opens.

Research and Development Forecast of China Pharmaceutical Chain Market Report, 2013-2017
M2 - Fri Jul 26, 8:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z55jsz/research_and) has announced the addition of the "Research and Development Forecast of China Pharmaceutical Chain Market, 2013-2017" report to their offering. Firstly the report makes the overview of China pharmaceutical circulation industry's development, makes the introduction and analysis of the industry's management system and related policies and further points out the future investment opportunities of China's pharmaceutical circulation field. Secondly it makes the deep analyses of the development status quo, advantages, existing problems and access barriers etc. of the pharmaceutical chain industry as well as the special chapter analysis of China's top 100 pharmaceutical retail enterprises. Lastly it makes the future development forecast of China's pharmaceutical chain, which can provide the decisive reference for the investment in the industry. Influencing by the rapid development of China's pharmaceutical industry and the increasing aging population, the pharmaceutical retail market develops rapidly, chain enterprises continuing the expansion and the number of the pharmacies increasing continuously. By the end of 2012, the sales amount of China's top 100 pharmaceutical retail enterprises reached CNY 87.877 billion, up 17.51% compared to last year, with the share of 39.06% in China's pharmaceutical retail market. The total number of branches of the top 100 enterprises' direct sale-stores was 50,418 in 2012, up 4.96% year on year. In the increasing market competition, the pharmaceutical retail market maintains the rapid development situation. With the promotion of the construction of Two Networks (pharmaceutical supply network and pharmaceutical monitoring network) and the reform of new cooperative medical care system in the rural areas, the rural pharmaceutical market gets the development, becoming the key areas of the future expansion of chain drugstores. With gradual perfect and comprehensive implementation of the new medical care system reform, China's pharmaceutical retail market ushers the wonderful development opportunity, the pharmaceutical chain industry entering the period of the strategic opportunity with brand development prospect. During the 12th-Five-Year period, the proportion of chain drugstores will account for two thirds of the total drugstores and will be equipped comprehensively with licensed pharmacists. Key Topics Covered: 1. Development of China's Pharmaceutical Circulation Industry 2. Overview of China's Pharmaceutical Chain Industry 3. Special Analysis of China's Top 100 Pharmaceutical Retail Enterprises 4. Key Enterprises of China's Pharmaceutical Chain 5. Future Development of China's Pharmaceutical Chain Companies Mentioned - China Nepstar Chain Drugstore Co., Ltd. - Chongqing Peace Pharmacy Chain Co., Ltd. - Chongqing Tongjunge Pharmacy Chain Store Co., Ltd. - Guangdong Dashenlin Chain Drugstore Co., Ltd. - Hubei Tongjitang Pharmacy Co., Ltd. - Liaoning CDFY Pharmacy Chain Co., Ltd. - Sinopharm Holding Guoda Drugstores Co., Ltd. - Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. For more information visit http://www.researchandmarkets.com/research/z5...search_and

BCOM, BEAT, NPD, EXXI, HF, TA Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Jul 08, 4:56AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of B Communications Ltd (NASDAQ:BCOM), CardioNet Inc (NASDAQ:BEAT), China Nepstar Chain Drugstore Ltd (NYSE:NPD), Energy XXI (Bermuda) Ltd (NASDAQ:EXXI), Hanfeng Evergreen Inc (NYSE:HF), TransAlta Corp (AMEX:TA) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Rite Aid Endorses Ken Martindale - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 25, 8:50AM CDT
Rite Aid Corp. put forward the name of Ken Martindale for the position of President and Chief Operating Officer.

Rite Aid Repeats Positive Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 21, 7:20AM CDT
Rite Aid posted a quarterly profit for the third consecutive quarter.

WEALTHMAKERS.COM Issues Bearish Research Reports on NEU, NPD, OMG, OSH, WMT
M2 - Tue Jun 11, 11:03AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Newmarket Corp (NYSE:NEU), China Nepstar Chain Drugstore Ltd (NYSE:NPD), OM Group Inc (NYSE:OMG), Orchard Supply Hardware Stores Corp (NASDAQ:OSH), Wal-Mart Stores Inc (NYSE:WMT)

China Nepstar Chain Drugstore Ltd (NPD) Stock Research Links

NPD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 5

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 17

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 10

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 7

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 5

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 8

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 8

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 5

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 6

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 9

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading

Top 5 Most Recently Viewed Articles

Freeport-McMoRan Faces Class Action Amidst Safety Allegations

Updated Category News Views 160

Understanding the Class Action Against Freeport-McMoRan Recently, a prominent securities law firm announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX), targeting potential securities fraud as stock prices drastically fell. This lawsuit follows serious allegations concerning the company's safety practices that may have played a part in significant...

Continue Reading
GRAIL Faces Lawsuit: Opportunity for Shareholder Action

Updated Category News Views 10

A Shaky Stage in GRAIL's Financial Play When you look at company dramas, GRAIL's latest saga is nothing short of a plot twist worthy of Wall Street headlines. The firm's recent misadventures have landed them in hot water—a securities fraud lawsuit. Investors, if you had a stake in this during the class period, it’s time to wake up and smell the potential losses....

Continue Reading
Breathe Drops: A Game-Changer for Respiratory Wellness

Updated Category News Views 294

Introducing Breathe Drops: A Revolutionary Wellness Solution In the ever-evolving world of wellness, Breathe is thrilled to unveil its latest product, Breathe Drops. This unique formula aims to enhance lung health and respiratory wellness by harnessing the power of carefully selected natural ingredients. Designed for individuals seeking natural wellness solutions, Breathe...

Continue Reading
aTyr Pharma Faces Class Action After Phase 3 Trial Setbacks

Updated Category News Views 180

Introduction to aTyr Pharma Inc. aTyr Pharma Inc. (NASDAQ: ATYR) is a biopharmaceutical company focused on developing therapies for serious diseases. The company’s innovative approach strives to improve patient outcomes through its protein therapeutics. Recent Developments In late 2025, aTyr Pharma faced a significant setback when it announced that its Phase 3 study for...

Continue Reading
Crucial Steps for EPSO-G's Upcoming Extraordinary Meeting

Updated Category News Views 65

Understanding EPSO-G's Extraordinary General Meeting EPSO-G, a key player in the energy sector, has taken an important step by convening an Extraordinary General Meeting (EGM). This decision was initiated by the Board of Energy Transmission and Exchange Group EPSO-G, representing a significant moment for the organization and its stakeholders. Purpose of the Meeting The...

Continue Reading